← Leaderboards
Tritia Yamasaki
University Of Kentucky
$807,365
Attributed
$807,365
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $275.4K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$807,365 · 1
VA$0 · 1
By mechanism
P20$807,365 · 1
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Bernard Mark Evers$41,615,341
- Michal J. Toborek$37,025,871
- Kurt Francis Hauser$27,368,955
- Rosemarie M Booze$13,099,681
- Lisa A Cassis$35,386,044
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposUniversitiesClinicSamplingPublishingTherapeutic InterventionDeep Brain StimulationGeneticParkinson DiseaseNerve DegenerationPathologyPlasmaAffectProteinsPathologicConsentDiagnosisBiological MarkersAlpha SynucleinKentuckyBloodMovement DisordersTissuesPrognosis
Grant awards (8)
Identifying Metabolomic Markers in Conversion to Cognitive Impairment in Parkinson's Disease$262,781
P20 · FY2025 · GM · contact PI
Identifying Metabolomic Markers in Conversion to Cognitive Impairment in Parkinson's Disease$269,184
P20 · FY2024 · GM · contact PI
Enhancing diagnosis of Parkinson's disease and multiple system atrophy via detection of alpha-synuclein seeding activity$0
IK2 · FY2024 · VA · contact PI
Identifying Metabolomic Markers in Conversion to Cognitive Impairment in Parkinson's Disease$275,400
P20 · FY2023 · GM · contact PI
Enhancing diagnosis of Parkinson's disease and multiple system atrophy via detection of alpha-synuclein seeding activity$0
IK2 · FY2023 · VA · contact PI
Enhancing diagnosis of Parkinson's disease and multiple system atrophy via detection of alpha-synuclein seeding activity$0
IK2 · FY2022 · VA · contact PI
Enhancing diagnosis of Parkinson's disease and multiple system atrophy via detection of alpha-synuclein seeding activity$0
IK2 · FY2021 · VA · contact PI
Enhancing diagnosis of Parkinson's disease and multiple system atrophy via detection of alpha-synuclein seeding activity$0
IK2 · FY2020 · VA · contact PI